Itonis Inc (PK) (ITNS)

Huuuuuummmm !There's something cooking♨️

Somebody is buying!

AI View of Licensing deal with Caring Brands
Sales of the over-the-counter (OTC) nausea relief product Emesyl are managed by Caring Brands Inc.. Caring Brands recently secured an exclusive global license to manufacture, market, and distribute the product, which was previously owned by Itonis Inc..
Current Status of Emesyl Sales
License Agreement: As of early January 2026, Caring Brands has the sole worldwide rights to the product.
Commercialization Plan: Caring Brands is assuming responsibility for the entire sales strategy, including manufacturing, marketing, and global distribution.
Market Opportunity: The company sees a significant market opportunity, citing a projected global nausea treatment market value exceeding $6.23 billion in 2025.
Sales Launch: The news articles indicate that the company plans to "revitalize and scale Emesyl's market presence" and are expected to launch a total of five products over the next two years. However, specific current sales figures or an exact public launch date for Emesyl under the new agreement are not detailed in the available press releases.

$ITNS An investor has to love this headline!
https://www.theglobeandmail.com/investing/markets/markets-news
$6.23 Billion Market Opportunity Via Exclusive Global License to Manufacture and Sell Emesyl OTC Nausea Relief Product by Caring Brands Inc. (Nasdaq: CABR)

$ITNS Itonis finally got it's "foot in the door" with a real company that can market Emesyl worldwide.
Caring Brands is going to "Do It All" for Itonis and Emesyl!

Does that means there is a chance to break .0005 barrier today? Deals seem very exciting with a Nasdaq company. .no joke though. The question is whether we will make a run or not...1000% gains will be nice to see. Lol

$ITNS Well, they just may have something happening.....FINALLY!
A licensing deal.
https://www.tradingview.com/news/tradingview:ede01069177b1:0-caring-brands-signs-license-agreement-with-itonis-pharmaceuticals/

So, what are "they" doing here?
222 and 3333 trades?
Did ITNS get that deal with CVS or what??

No volume is good volume in this otc

NO VOLUME TODAY

20m dumps yesterday. Makes no sense. This looks like a great bottom bouncer imo

ITNS
Itonis Inc (PK)
0.0004
0.00 (0.00%)
Volume: -
Bid: 0.0003
Ask: 0.0004

no volume

Looks like this one is cooked

ITNS
Itonis Inc (PK)
0.0004
-0.0001 (-20.00%)
Volume: 100,000
Day Range: 0.0004 - 0.000425
Last Trade Time: 3:44:24 PM EDT

Pink current again

Not looking so

Lame back to 0004 after .0012s…. Why? Still waiting to figure out what’s happening here

Take a look at CEOS.. Time to start adding?

bottom is 0004

Ya just gotta ask WHY????
OTC Disclosure & News
ActiveInactiveAll
PUBLISH DATE TITLE PERIOD END DATE STATUS
04/15/2024 Quarterly Report - Itonis's Quarterly Report, ending February 29, 2024 02/29/2024 A
03/25/2024 Attorney Letter with Respect to Current Information - Attorney letter with respect to ITNS current information, corrected 11/30/2023 A
03/20/2024 Attorney Letter with Respect to Current Information - Attorney Letter with respect to Current Information, Itonis, ending Nov 30, 2023 11/30/2023 A
01/16/2024 Annual Report - Itonis' Annual Report, ending November 30, 2023 11/30/2023 A
01/16/2024 Quarterly Report - Itonis' Quarterly Report, ending August 31, 2023 08/31/2023 A

Quarterly out today
"B. Describe the issuers’ principal products or services.
In 2012, the Company launched a new Itonis Pharmaceuticals division to produce and market over the counter
and prescription homeopathic preparations to treat both common ailments and chronic diseases. The Company
has launched the retails sale of the Emesyl® nausea relief product. The Company has identified the market for
its Emesyl® product line as the general public who suffers from nausea. Emesyl® has been available for
purchase at https://www.amazon.com/dp/B00U20H3KI and www.Emesyl.com.
In 2021, the Company agreed with CVS Pharmacy to participate in their Test & Learn Program for our Emesyl®
product. We fulfilled various purchase orders from CVS which involved shipping Emesyl® products to two CVS
distribution centers in Texas. We had expected to gather feedback with performance metrics via an online
dashboard to develop action plans for sales success. CVS seemed to like the uniqueness of Emesyl® with it
being “Homeopathic” and the “only fast acting nasal spray” on the market. If the success criteria are met, an
action plan will be developed by the CVS category manager to expand distribution to more of their stores, which
is typically executed in their next CVS planogram cycle. We will see what the Test & Learn Program will tell us.
Meanwhile, the Company’s Itonis Holdings, Inc. subsidiary owns and manages the entirety of the Emesyl®
nausea relief product line by full assignment of all the patent rights in Emesyl® nausea relief from the inventor.
The Company has organized said Itonis Pharmaceuticals division and its Emesyl® and Emesyl® Product line
within its wholly-owned subsidiary, Itonis Holdings, Inc.
On or about March 28, 2023, the Company transferred its Emesyl Plus product to Smart Cannabis Inc. in
exchange for 147,000,000 shares of Smart Cannabis, Inc’s common stock."

Smart Cannabis Corp. (SCNA)

Someone(s) scooping up a lot of shares.
Is anyone here buying or just holding like me?

need a pump

big hits

added more BLEG with those funds for today, pennystock worthy imo as for ITNS even day atleast

NBCO came from 01, daily chart higher highs higher lows up 200% watch for big dip.. buy into dip

https://www.stockscores.com/charts/charts/?ticker=nbco

Beauty

https://stockcharts.com/c-sc/sc?s=ITNS&p=D&b=5&g=0&i=t9926882964c&r=1712264746658

stair stepper formed on daily chart, may sell my BLEG for a loss and load even more here

https://stockcharts.com/c-sc/sc?s=ITNS&p=D&b=5&g=0&i=t9926882964c&r=1712264746658

Very nice

next batch of funds for tomorrow,no pump crew needed here lol

ITNS touched 001 today. Watching for the next leg to start

this one moves fast as lightning

yes sir, i question BEGI GGSM,im in BLEG

Break 0013 and fun starts

https://stockcharts.com/c-sc/sc?s=ITNS&p=W&b=5&g=0&i=t8185344496c&r=1712170662420

Looking good hete

like paper

was at 0002 not long ago

You have a point

Very interesting…. Looks like somebody stashed dozens of millions of shares last Thursday before the holiday… definitely worth watching because something like that indicates someone or someones know something coming out soon or happening news that we don’t.

low float

wow

Maybe the CVS deal????????

01/16/2024
Annual Report - Itonis' Annual Report, ending November 30, 2023

Describe the issuers’ principal products or services.

"In 2021, the Company agreed with CVS Pharmacy to participate in their Test & Learn Program for our Emesyl®
product. We fulfilled various purchase orders from CVS which involved shipping Emesyl® products to two CVS
distribution centers in Texas. We had expected to gather feedback with performance metrics via an online
dashboard to develop action plans for sales success. CVS seemed to like the uniqueness of Emesyl® with it
being “Homeopathic” and the “only fast acting nasal spray” on the market. If the success criteria are met, an
action plan will be developed by the CVS category manager to expand distribution to more of their stores, which
is typically executed in their next CVS planogram cycle. We will see what the Test & Learn Program will tell us"

What’s going on profit, I haven’t even looked at my E*TRADE account in a while, because it just fill up a bunch of lame penny stocks, so I decided to look today, and wow, somethings going on

$ITNS Don't know why pink current now........Maybe the CVS deal????????

01/16/2024
Annual Report - Itonis' Annual Report, ending November 30, 2023

Describe the issuers’ principal products or services.

"In 2021, the Company agreed with CVS Pharmacy to participate in their Test & Learn Program for our Emesyl®
product. We fulfilled various purchase orders from CVS which involved shipping Emesyl® products to two CVS
distribution centers in Texas. We had expected to gather feedback with performance metrics via an online
dashboard to develop action plans for sales success. CVS seemed to like the uniqueness of Emesyl® with it
being “Homeopathic” and the “only fast acting nasal spray” on the market. If the success criteria are met, an
action plan will be developed by the CVS category manager to expand distribution to more of their stores, which
is typically executed in their next CVS planogram cycle. We will see what the Test & Learn Program will tell us"

Looks alive to me

Where can we read the CVS news?

i didn't see that. looked at the OTC news on it and last one was in 2018.